Fielder Capital Group LLC Buys 211 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fielder Capital Group LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the first quarter, Holdings Channel.com reports. The fund owned 4,824 shares of the healthcare conglomerate’s stock after acquiring an additional 211 shares during the quarter. Fielder Capital Group LLC’s holdings in UnitedHealth Group were worth $2,527,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $30,000. Kapitalo Investimentos Ltda acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $41,000. Finally, Copia Wealth Management acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $42,000. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

UNH has been the subject of a number of research reports. Mizuho reduced their price objective on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Baird R W lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $392.29.

UnitedHealth Group Price Performance

UNH opened at $280.69 on Monday. The stock has a market capitalization of $254.62 billion, a P/E ratio of 11.75, a PEG ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The stock has a 50-day moving average price of $301.58 and a 200-day moving average price of $424.22. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 3.15%. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director directly owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 over the last three months. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.